Search research articles
Contact Us
Filters
Showing results (211-220 of 236) with videos related to
Page
of 24
Sort By:
Journal of Translational Medicine
|
May 4, 2012
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"
Paolo A Ascierto, Antonio M Grimaldi, Brendan Curti, et al.
Journal of Translational Medicine
|
September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)
Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Journal of Translational Medicine
|
September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)
Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19
Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Journal for Immunotherapy of Cancer
|
June 29, 2023
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas
Andrew L Coveler, David C Smith, Tycel Phillips, et al.
Clinical Pharmacology and Therapeutics
|
November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia
Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Cell
|
October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Journal of Cancer Research and Clinical Oncology
|
December 7, 2016
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
Thomas M Atkinson, Jennifer L Hay, Alexander Shoushtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
F Stephen Hodi, Christopher L Corless, Anita Giobbie-Hurder, et al.
JCO Precision Oncology
|
November 29, 2022
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit
Daniel F Hayes, Roy S Herbst, Jonathan L Myles, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 236) with videos related to
Sort By:
Page
of 24
Journal of Translational Medicine
|
May 4, 2012
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"
Paolo A Ascierto, Antonio M Grimaldi, Brendan Curti, et al.
Journal of Translational Medicine
|
September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)
Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Journal of Translational Medicine
|
September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)
Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19
Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Journal for Immunotherapy of Cancer
|
June 29, 2023
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas
Andrew L Coveler, David C Smith, Tycel Phillips, et al.
Clinical Pharmacology and Therapeutics
|
November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia
Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.
Cell
|
October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Journal of Cancer Research and Clinical Oncology
|
December 7, 2016
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
Thomas M Atkinson, Jennifer L Hay, Alexander Shoushtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
F Stephen Hodi, Christopher L Corless, Anita Giobbie-Hurder, et al.
JCO Precision Oncology
|
November 29, 2022
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit
Daniel F Hayes, Roy S Herbst, Jonathan L Myles, et al.
Page
of 24